169 related articles for article (PubMed ID: 35015289)
1. Correlation Between Circulating Adropin Levels and Patients with PCOS: An Updated Systematic Review and Meta-analysis.
Ke Y; Hu J; Zhu Y; Wang Y; Chen S; Liu S
Reprod Sci; 2022 Dec; 29(12):3295-3310. PubMed ID: 35015289
[TBL] [Abstract][Full Text] [Related]
2. Adropin levels and its associations as a fat-burning hormone in patients with polycystic ovary syndrome: a correlational meta-analysis.
Varikasuvu SR; Reddy EP; Thangappazham B; Varshney S; Das VL; Munikumar M
Gynecol Endocrinol; 2021 Oct; 37(10):879-884. PubMed ID: 34241553
[TBL] [Abstract][Full Text] [Related]
3. Circulating kisspeptin and anti-müllerian hormone levels, and insulin resistance in women with polycystic ovary syndrome: A systematic review, meta-analysis, and meta-regression.
Pérez-López FR; Ornat L; López-Baena MT; Santabárbara J; Savirón-Cornudella R; Pérez-Roncero GR
Eur J Obstet Gynecol Reprod Biol; 2021 May; 260():85-98. PubMed ID: 33744505
[TBL] [Abstract][Full Text] [Related]
4. Potential effects of adropin on systemic metabolic and hormonal abnormalities in polycystic ovary syndrome.
Ye Z; Zhang C; Zhao Y
Reprod Biomed Online; 2021 May; 42(5):1007-1014. PubMed ID: 33612434
[TBL] [Abstract][Full Text] [Related]
5. Adropin in women with polycystic ovary syndrome.
Kuliczkowska-Płaksej J; Mierzwicka A; Jończyk M; Stachowska B; Urbanovych A; Bolanowski M
Endokrynol Pol; 2019; 70(2):151-156. PubMed ID: 30480749
[TBL] [Abstract][Full Text] [Related]
6. Metabolic characteristics of obese patients with polycystic ovarian syndrome: a meta-analysis.
Pan X
Gynecol Endocrinol; 2023 Dec; 39(1):2239934. PubMed ID: 37524309
[TBL] [Abstract][Full Text] [Related]
7. Asprosin levels in women with and without the polycystic ovary syndrome: a systematic review and meta-analysis.
Pérez-López FR; López-Baena MT; Pérez-Roncero GR; Chedraui P; Varikasuvu SR; García-Alfaro P
Gynecol Endocrinol; 2023 Dec; 39(1):2152790. PubMed ID: 36480935
[No Abstract] [Full Text] [Related]
8. A possible connection between tumor necrosis factor alpha and adropin levels in polycystic ovary syndrome.
Kume T; Calan M; Yilmaz O; Kocabas GU; Yesil P; Temur M; Bicer M; Calan OG
J Endocrinol Invest; 2016 Jul; 39(7):747-54. PubMed ID: 26969461
[TBL] [Abstract][Full Text] [Related]
9. Association of Luteinizing hormone and LH receptor gene polymorphism with susceptibility of Polycystic ovary syndrome.
Deswal R; Nanda S; Dang AS
Syst Biol Reprod Med; 2019 Oct; 65(5):400-408. PubMed ID: 30958034
[TBL] [Abstract][Full Text] [Related]
10. Idiopathic hirsutism and dyslipidemia: A systematic review, meta-analysis, and meta-regressions.
Amiri M; Mahmoudieh L; Sheidaei A; Ramezani Tehrani F
J Cosmet Dermatol; 2023 May; 22(5):1449-1462. PubMed ID: 36718809
[TBL] [Abstract][Full Text] [Related]
11. The impact of serum adropin and ischemia modified albumin levels based on BMI in PCOS.
Inal ZO; Erdem S; Gederet Y; Duran C; Kucukaydin Z; Kurku H; Sakarya DK
Endokrynol Pol; 2018; 69(2):135-141. PubMed ID: 29465156
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and Safety of Coenzyme Q10 Supplementation in the Treatment of Polycystic Ovary Syndrome: a Systematic Review and Meta-analysis.
Zhang T; He Q; Xiu H; Zhang Z; Liu Y; Chen Z; Hu H
Reprod Sci; 2023 Apr; 30(4):1033-1048. PubMed ID: 35941510
[TBL] [Abstract][Full Text] [Related]
13. Adropin levels in women with polycystic ovaries undergoing ovarian stimulation: correlation with lipoprotein lipid profiles.
Bousmpoula A; Kouskouni E; Benidis E; Demeridou S; Kapeta-Kourkouli R; Chasiakou A; Baka S
Gynecol Endocrinol; 2018 Feb; 34(2):153-156. PubMed ID: 28937295
[TBL] [Abstract][Full Text] [Related]
14. Adropin: a key component and potential gatekeeper of metabolic disturbances in policystic ovarian syndrome.
Yildirim B; Celik O; Aydin S
Clin Exp Obstet Gynecol; 2014; 41(3):310-2. PubMed ID: 24992783
[TBL] [Abstract][Full Text] [Related]
15. Correlation analysis of myonectin levels with metabolic and hormonal disorders in patients with polycystic ovary syndrome.
Zhang J; Chen L; Ye J
Ann Palliat Med; 2021 Mar; 10(3):3404-3409. PubMed ID: 33752430
[TBL] [Abstract][Full Text] [Related]
16. Levels of lipoprotein and homocysteine in non-obese and obese patients with polycystic ovary syndrome.
Yilmaz M; Biri A; Bukan N; Karakoç A; Sancak B; Törüner F; Paşaoğlu H
Gynecol Endocrinol; 2005 May; 20(5):258-63. PubMed ID: 16019370
[TBL] [Abstract][Full Text] [Related]
17. Cardiometabolic health in offspring of women with PCOS compared to healthy controls: a systematic review and individual participant data meta-analysis.
Gunning MN; Sir Petermann T; Crisosto N; van Rijn BB; de Wilde MA; Christ JP; Uiterwaal CSPM; de Jager W; Eijkemans MJC; Kunselman AR; Legro RS; Fauser BCJM
Hum Reprod Update; 2020 Jan; 26(1):103-117. PubMed ID: 31867675
[TBL] [Abstract][Full Text] [Related]
18. The efficacy and safety of metformin combined with simvastatin in the treatment of polycystic ovary syndrome: A meta-analysis and systematic review.
Liu Y; Shao Y; Xie J; Chen L; Zhu G
Medicine (Baltimore); 2021 Aug; 100(31):e26622. PubMed ID: 34397797
[TBL] [Abstract][Full Text] [Related]
19. [Relationship between the triglyceride/high-density lipoprotein-cholesterol ratio, insulin resistance index and cardiometabolic risk factors in women with polycystic ovary syndrome].
Roa Barrios M; Arata-Bellabarba G; Valeri L; Velázquez-Maldonado E
Endocrinol Nutr; 2009 Feb; 56(2):59-65. PubMed ID: 19627713
[TBL] [Abstract][Full Text] [Related]
20. [Monocyte chemoattractant protein-1 and its correlation with lipoprotein in polycystic ovary syndrome].
Hu WH; Qiao J; Zhao SY; Zhang XW; Li MZ
Beijing Da Xue Xue Bao Yi Xue Ban; 2006 Oct; 38(5):487-91. PubMed ID: 17068620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
